Free equity investment tool of Japanese companies

Credit Rating Analysis

Annual

First quarter

Second quarter

Third quarter

Sponsored Link

Related Company

kyowa Hakko Kirin

MITSUBISHI PLASTICS

Sumitomo Seika Chemicals

AIR WATER

Chugoku Marine Paints

Eisai

KOSE

SANKO GOSEI

NITTO FC

TOYO INK SC HOLDINGS

Milbon

日本新薬

DAINICHISEIKA COLOR & CHEMICALS MFG.

参天製薬

日油

EDIUNET Related Ranking

EDIUNET

EDIUNET Credit Rating

EDIUNET Industry Avg

EDIUNET Prefectures

Yuho! Industry

EDIUNET Rating News

Prev « 2024-04 » Next

Mon	Tue	Wed	Thu	Fri	Sat	Sun
1 -	2 -	3 -	4 -	5 -	6 -	7 -
8 -	9 -	10 -	11 -	12 -	13 -	14 -
15 -	16 -	17 -	18 -	19 -	20 -	21 -
22 -	23 -	24 -	25 -	26 -	27 -	28 -
29 -	30 -

[Update list]

1/28 Retail Trade (CAWACHI:A etc...

1/27 Banks (The Awa Bank:BBB→A)

1/23 Chemicals (Milbon:AA→AAA)

1/21 Glass & Ceramics Products (..

1/21 Machinery (TSUDAKOMA:C)

1/21 Other Services (Netindex.:CC)

1/20 Other Products (Kurogane Kos..

1/20 Wholesale Trade (リーバイ・..

1/20 Other Services (川崎地質:BB→..

1/17 Chemicals (Kawaguchi Chemica..

 RSS

 Company RSS

 Daily RSS

Sponsored Link

Recently Download Chart

メルコホールディングス

Nittetsu Mining

Renesas Electronics

PIONEER etc.

KIKUSUI ELECTRONICS etc.

Credit Rating Analysis: SATO PHARMACEUTICAL (Annual )

The details of credit rating (bankruptcy risk) can be checked. A credit rating in nine stages (AAA-C).

【Analysis Menu】 Outline Statement Rating Indicator Download

Sponsored Link

Credit Rating (Bankruptcy Risk): SATO PHARMACEUTICAL (Annual ) Consolidated | Non-Consolidated

Date	Credit Rating	Comment	Sales	Current Profit	Net Income
2013-07-31	AA	Credit is very high, slightly affected by biz environs.	¥ 38 B 4.35%	¥ 3 B 21.73%	¥ 2 B 71.25%

Financial Timeline

Date	-  (First quarter )	-  (Third quarter )	2011-01-31  (Second quarter )	2013-07-31  (Annual )
Credit Rating	-	-	AAA	AA
Total Assets	-	-	¥ 93 B	¥ 100 B
Net Assets	-	-	¥ 81 B	¥ 87 B

Financial Statement Risk Analysis: SATO PHARMACEUTICAL (Annual ) (Consolidated )

Special note

Net sales has increased 5 consecutive terms. The performance is good.

Net Assets have increased 5consecutive terms. The fiscal base is getting better.

Cash(¥ 23 B) is more than the total liabilities(¥ 13 B). It is a very steady fiscal base!

[Date: 2013-07-31]  Danger : Warning : Caution : Good

Financing Good (*Operating Cash Flow is plus )
Investment Cash Flow (¥ -5 B) & Financial Cash Flow (¥ -578 M) is a minus, Operating Cash Flow (¥ 5 B) is a plus,

Dividend
Under the situation of Net Income (¥ 2 B) & Operating Cash Flow (¥ 5 B) , Dividend (¥ -101 M) is paid.

Financing Risk (*Operating Cash Flow is decrease )
Sales (¥ 38 B) is first term (¥ 36 B) more, however Operating Cash Flow (¥ 5 B) is first term (¥ 5 B) less , there is a possibility that the financing has deteriorated very much.

[Date: 2012-07-31]  Danger : Warning : Caution : Good

Management Risk (*Net Income is decrease )
Net Income (¥ 1 B) is first term Net Income (¥ 1 B) less , there is a possibility that the management situation has stagnated and deteriorated

Management Risk (*Net Profit Margin is decrease )
Net Profit Margin (3.93％) is first term Net Profit Margin (4.12％) less , there is a possibility that the profitability has deteriorated.

Financing Good (*Operating Cash Flow is plus )
Investment Cash Flow (¥ -2 B) & Financial Cash Flow (¥ -410 M) is a minus, Operating Cash Flow (¥ 5 B) is a plus,

Dividend
Under the situation of Net Income (¥ 1 B) & Operating Cash Flow (¥ 5 B) , Dividend (¥ -101 M) is paid.

[Date: 2011-07-31]  Danger : Warning : Caution : Good

Management Risk (*Gross Income is decrease )
Gross Income (¥ 12 B) is first term Gross Income (¥ 12 B) less , there is a possibility that the management situation has stagnated and deteriorated

Financing Good (*Operating Cash Flow is plus )
Investment Cash Flow (¥ -4 B) & Financial Cash Flow (¥ -373 M) is a minus, Operating Cash Flow (¥ 5 B) is a plus,

Dividend
Under the situation of Net Income (¥ 1 B) & Operating Cash Flow (¥ 5 B) , Dividend (¥ -101 M) is paid.

[Date: 2010-07-31]  Danger : Warning : Caution : Good

Financing Good (*Operating Cash Flow is plus )
Investment Cash Flow (¥ -2 B) & Financial Cash Flow (¥ -258 M) is a minus, Operating Cash Flow (¥ 3 B) is a plus,

Dividend
Under the situation of Net Income (¥ 1 B) & Operating Cash Flow (¥ 3 B) , Dividend (¥ -101 M) is paid.

Financing Risk (*Operating Cash Flow is decrease )
Sales (¥ 35 B) is first term (¥ 35 B) more, however Operating Cash Flow (¥ 3 B) is first term (¥ 3 B) less , there is a possibility that the financing has deteriorated very much.

[Date: 2009-07-31]  Danger : Warning : Caution : Good

Management Risk (*Net Income is minus or 0 )
Net Income (¥ -736 M) is minus or 0, so , there is a possibility that the management situation is severe.

Financing Good (*Operating Cash Flow is plus )
Investment Cash Flow (¥ -2 B) & Financial Cash Flow (¥ -352 M) is a minus, Operating Cash Flow (¥ 3 B) is a plus,

Dividend Risk
Under the situation of Net Income (¥ -736 M) & Operating Cash Flow (¥ 3 B), Dividend (¥ -102 M) is paid.

Credit Rating (Bankruptcy Risk): SATO PHARMACEUTICAL (Annual ) Consolidated | Non-Consolidated

Date	Credit Rating	Comment	Sales	Current Profit	Net Income
2013-07-31	AAA	Credit is extremely high. The highest rating.	¥ 37 B 3.91%	¥ 3 B 21.41%	¥ 2 B 69.45%

Financial Timeline

Date	-  (First quarter )	-  (Third quarter )	2011-01-31  (Second quarter )	2013-07-31  (Annual )
Credit Rating	-	-	A	AAA
Total Assets	-	-	¥ 93 B	¥ 99 B
Net Assets	-	-	¥ 81 B	¥ 86 B

Financial Statement Risk Analysis: SATO PHARMACEUTICAL (Annual ) (Non-Consolidated )

Special note

Net sales has increased 5 consecutive terms. The performance is good.

Net Assets have increased 5consecutive terms. The fiscal base is getting better.

Cash(¥ 22 B) is more than the total liabilities(¥ 13 B). It is a very steady fiscal base!

[Date: 2013-07-31]  Danger : Warning : Caution : Good

Dividend
Under the situation of Net Income (¥ 2 B) & Operating Cash Flow (-) , Dividend (¥ -101 M) is paid.

[Date: 2012-07-31]  Danger : Warning : Caution : Good

Management Risk (*Net Income is decrease )
Net Income (¥ 1 B) is first term Net Income (¥ 1 B) less , there is a possibility that the management situation has stagnated and deteriorated

Management Risk (*Net Profit Margin is decrease )
Net Profit Margin (3.95％) is first term Net Profit Margin (4.10％) less , there is a possibility that the profitability has deteriorated.

Dividend
Under the situation of Net Income (¥ 1 B) & Operating Cash Flow (-) , Dividend (¥ -101 M) is paid.

[Date: 2011-07-31]  Danger : Warning : Caution : Good

Dividend
Under the situation of Net Income (¥ 1 B) & Operating Cash Flow (-) , Dividend (¥ -102 M) is paid.

[Date: 2010-07-31]  Danger : Warning : Caution : Good

Dividend
Under the situation of Net Income (¥ 1 B) & Operating Cash Flow (-) , Dividend (¥ -102 M) is paid.

[Date: 2009-07-31]  Danger : Warning : Caution : Good

Management Risk (*Net Income is minus or 0 )
Net Income (¥ -782 M) is minus or 0, so , there is a possibility that the management situation is severe.

Dividend
Under the situation of Net Income (¥ -782 M) & Operating Cash Flow (-) , Dividend (¥ -102 M) is paid.

Related Information: SATO PHARMACEUTICAL (Annual )

Statement Type

Annual : SATO PHARMACEUTICAL

Second quarter : SATO PHARMACEUTICAL

Analysis Menu

Outline : SATO PHARMACEUTICAL

Statement : SATO PHARMACEUTICAL

Rating : SATO PHARMACEUTICAL

Indicator : SATO PHARMACEUTICAL

Download : SATO PHARMACEUTICAL

Industry Comparison Ranking

Chemicals - EDIUNET Industry Rankings

Chemicals - EDIUNET Credit Rating

Chemicals - EDIUNET Industry Avg

Comparison with a neighboring company

Tokyo - EDIUNET Prefectures

Tokyo港区 - EDIUNET Prefectures

Related company's newest statement

Date	Company	Credit Rating	Date
1/23	Milbon	AA→AAA	2013-12-20
1/17	Kawaguchi Chemical Indu..	BBB→BB	2013-11-30
1/17	SANKEI CHEMICAL	A	2013-11-30
1/15	HOKKO CHEMICAL INDUSTRY	BB→B	2013-11-30
1/15	Daito Pharmaceutical Co .	AA	2013-11-30 (Q2)
1/15	KAWAKAMI PAINT MFG.	B→BB	2013-11-30
1/15	旭化学工業	AA	2013-11-30 (Q1)
1/10	OSAKA ORGANIC CHEMICAL ..	BB→BBB	2013-11-30
1/10	HISAMITSU PHARMACEUTICAL	A	2013-11-30 (Q3)
1/10	AMS Life Science	BBB→BB	2013-11-30 (Q1)

EDIUNET Investment News (Chemicals)

1/23 Chemicals (Milbon:AA→AAA)

1/17 Chemicals (Kawaguchi Chemica..

1/15 Chemicals (HOKKO CHEMICAL IN..

1/10 Chemicals (OSAKA ORGANIC CHE..

1/9 Chemicals (SANKO GOSEI:A)

12/27 Chemicals (Niitaka:A)

12/18 Chemicals (KUMIAI CHEMICAL I..

12/12 Chemicals (IHARA CHEMICAL IN..

12/11 Chemicals (Konoshima Chemica..

12/10 Chemicals (NATOCO:AA)

Company Information

Ticker	Market	Industry	Month	report	Rating
SATO PHARMACEUTICAL			Chemicals	7	Annual	AA

Related Company

参天製薬 (Sales ¥ 119 B)

KOSE (Sales ¥ 170 B)

KAKEN PHARMACEUTICAL (Sales ¥ 87 B)

日本新薬 (Sales ¥ 69 B)

タキロン (Sales ¥ 67 B)

POLA ORBIS HOLDINGS (Sales ¥ 180 B)

DAINICHISEIKA COLOR & CHEMICALS MFG. (Sales ¥ 151 B)

Sumitomo Seika Chemicals (Sales ¥ 70 B)

MATSUMOTO YUSHI-SEIYAKU (Sales ¥ 27 B)

Sumitomo Bakelite (Sales ¥ 183 B)

ZEON (Sales ¥ 250 B)

Eisai (Sales ¥ 573 B)

JSP (Sales ¥ 96 B)

関連する株式投資情報

EDIUNET Caution

*Financial data might be different from the actual one. Please confirm the original, and read Caution.

*This site has obtained the information from the FSA's EDINET, Tokyo Stock Exchange's TDnet and Pay statistical data services, Fukuoka stock Exchange's Stock market capitalization, Center for Spatial Information Science's CSV Geocoding Service. The copyright of the information belongs to each corporation etc. .